Pharmaceutical News

UAE Launches Groundbreaking Study to Prevent Alzheimer’s Disease Using Genomics

/ July 7, 2026

A major healthcare initiative in the UAE has just begun a first-of-its-kind clinical trial that uses genetic testing to try […]

/ July 6, 2026

During the CPHI Barcelona conference in October, European Pharmaceutical Review spoke with Julien Lamps, an expert from Lonza CHI, about

/ July 5, 2026

Scientists have developed a much simpler way to manufacture a key ingredient in some of the most popular type 2

/ July 4, 2026

In this interview, Torsten Madsen, CEO of Hoba Therapeutics, shares insights about the challenges and opportunities in developing new medications

/ July 3, 2026

AlzeCure Pharma, a Swedish pharmaceutical company, has signed a major deal with QuantumCell ApS, a Danish biotechnology company. This agreement

/ July 1, 2026

The pharmaceutical company Lundbeck will present new findings about migraine treatments at the European Academy of Neurology Congress 2026, held

/ June 30, 2026

The European Directorate for the Quality of Medicines & HealthCare (EDQM) has updated twenty guidelines to phase out the use

/ June 29, 2026

MSD, a pharmaceutical company, has welcomed a new recommendation from the National Institute for Health and Care Excellence (NICE) in

/ June 28, 2026

The European Commission has approved a new treatment option for adults with a specific type of advanced colon cancer that

/ June 27, 2026

Agomab Therapeutics has designed a new Phase 2b clinical trial called NOV-ERA to test its experimental drug, ontunisertib, for treating